Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...

More than 20 years after gaining FDA approval for Flovent, GSK still controlled the market in the U.S. for the asthma inhaler through a partnership with an “authorized generic” dealer, a setup that ...

Supreme Court struck down tariffs, no refund guidance provided New 10% tariffs imposed by Trump face legal challenges Fedex, Costco sued by customers to pass along refunds March 12 (Reuters) - The U.S ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Senate leaders are urging the Department of Defense to ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

6.0.428 [C:\Program Files\dotnet\sdk] 8.0.413 [C:\Program Files\dotnet\sdk] 9.0.109 [C:\Program Files\dotnet\sdk] 9.0.306 [C:\Program Files\dotnet\sdk] If this is a report about a bug in an analyzer, ...

Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a second generic form of mifepristone. HHS is reportedly reviewing mifepristone after state ...

The Association for Accessible Medicines and the Biosimilars Council have released the 2025 U.S. Generic & Biosimilar Medicines Savings Report. AAM’s annual savings report highlights that generic and ...